YWYu‐Ling Wu

Yu‐Ling Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu‐Ling Wu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chaobin Pan

    Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Dong-Xiao Tang

    Department of Stomatology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Hong‐Yu Li

    Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China

    1 shared publication
  • Jiu‐Yang Jiao

    Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China

    1 shared publication
  • Ling‐Jian Yan

    Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China

    1 shared publication
  • Quan Wan

    Department of Oral & Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Mesenchymal stem cell‐derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells

    by Yu‐Ling Wu, Hong‐Yu Li, Xiao‐Peng Zhao, Jiu‐Yang Jiao, Dong‐Xiao Tang, Ling‐Jian Yan, Quan Wan, Chao‐Bin Pan

    Recent studies have demonstrated that mesenchymal stem cells (MSC) exhibit a tropism to tumors and form the tumor stroma. In addition, we found that MSC can secrete different types of factors. However, the involvement of MSC‐derived factors in human tongue squamous cell carcinoma (TSCC) growth has not been clearly addressed. The CCN family includes multifunctional signaling molecules that affect the initiation and development events of various tumors. In our study, we report that CCN2/connective tissue growth factor (CTGF) was the most highly induced among the CCN family members in MSC that were co‐cultured with TSCC cells. To evaluate the relationship between CCN2 and TSCC growth, we downregulated MSC‐derived CCN2 expression with shRNA targeting CCN2 and found that MSC‐secreted CCN2 promotes TSCC cell proliferation, migration and invasion. We also confirmed that MSC‐derived CCN2 partially accelerated tumor growth in vitro. Taken together, these results suggest that MSC‐derived CCN2 contributes to the promotion of proliferation, migration and invasion of TSCC cells and may be a possible therapy target in the future.